ADC Control Human IgG1-JSSW-001
ADC Control Human IgG1-JSSW-001 is the isotype control for ADC SYS6010 (HY-185832). SYS6010 is an antibody-drug conjugate (ADC) targeting epidermal growth factor receptor (EGFR), which is formed by conjugating the anti-EGFR humanized IgG1 monoclonal antibody Becotatug (HY-P990049) with the topoisomerase I inhibitor JS-1 (HY-178217) via a cleavable tetrapeptide linker. SYS6010 can be used in the research of advanced solid tumors such as non-small cell lung cancer.
For research use only. We do not sell to patients.
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Isotype control ADCs match only the antibody backbone and lack antigen-binding capability; they are used to rule out non-specific toxicity and off-target effects associated with the antibody backbone, linker, or toxin.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
SMILES
[ADC Control Human IgG1-JSSW-001]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
- ADC Control Human IgG1-JSSW-001
- Antibody-Drug Conjugates (ADCs)
- EGFR
- Topoisomerase
- EGFR wild-type nonsquamous non-small cell lung cancer
- advanced solid tumors
- EGFR-mutant nonsquamous non-small cell lung cancer
- anti-EGFR humanized IgG1 monoclonal antibody
- antibody drug conjugate
- advanced esophageal squamous cell carcinoma
- topoisomerase I inhibitor
- epidermal growth factor receptor
- non-small cell lung cancer
- Inhibitor
- inhibitor
- inhibit